Notch Signaling Molecules Activate TGF-βin Rat Mesangial Cells under High Glucose Conditions
Author(s) -
Li Liu,
Chenlin Gao,
Guo Chen,
Xia Li,
Jia Li,
Qin Wan,
Yong Xu
Publication year - 2013
Publication title -
journal of diabetes research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.034
H-Index - 50
eISSN - 2314-6753
pISSN - 2314-6745
DOI - 10.1155/2013/979702
Subject(s) - notch signaling pathway , diabetic nephropathy , transforming growth factor , fibrosis , signal transduction , pathogenesis , kidney , hes3 signaling axis , fibronectin , endocrinology , nephropathy , cancer research , microbiology and biotechnology , medicine , biology , diabetes mellitus , extracellular matrix
The involvement of the Notch signaling pathway in the cellular differentiation of the mammalian kidney is established. Recently, the dysregulation of Notch signaling molecules has been identified in acute and chronic renal injuries, fibrosis models, and diabetic kidney biopsies. The canonical Notch ligand , Jagged1, is upregulated in a transforming growth factor-beta- (TGF- β -) dependent manner during chronic kidney disease. TGF- β , a central mediator of renal fibrosis, also is a major contributor to the development of diabetic nephropathy. To explore the roles and possible mechanisms of Notch signaling molecules in the pathogenesis of diabetic nephropathy, we exposed cultured rat mesangial cells to a γ -secretase inhibitor (DAPT) or high glucose and measured the expression of Notch signaling molecules and the fibrosis index. Notch pathway-related molecules, TGF- β , and fibronectin increased with exposure to high glucose and decreased with DAPT treatment. Our results suggest that the Notch signaling pathway may precipitate diabetic nephropathy via TGF- β activation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom